MarketPulse
R

$RGC

15 articles found
1 positive
14 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

ImmunityBio Hit with Class Action Over Anktiva Claims; Deadline Looms for Investors

Class action lawsuit filed against ImmunityBio over Anktiva misstatement claims. Lead plaintiff deadline May 26, 2026.
IBRXRGCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Regencell Bioscience Faces Class Action Over Alleged Market Manipulation Disclosures

Class action lawsuit filed against Regencell Bioscience for alleged false statements about market manipulation vulnerability and regulatory risks. Lead plaintiff deadline: June 23, 2026.
RGCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Regencell Bioscience Hit with Class Action Lawsuit Over Market Manipulation Claims

Class action lawsuit filed against Regencell Bioscience for alleged false statements regarding market manipulation vulnerability and regulatory exposure. Lead plaintiff deadline: June 23, 2026.
RGCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Securities Class Actions Target Regencell, Globant, Nektar Over Alleged Misstatements

Rosen Law Firm files class actions against $RGC, $GLOB, $NKTR alleging false statements. Investors have until June 23, 2026 to become lead plaintiffs.
RGCNKTRGLOBsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Class Action Filed Against Regencell Over Allegedly False Statements on Operations

Class action filed against Regencell Bioscience for allegedly false statements on operations and market manipulation vulnerabilities affecting investors during October 2024-October 2025 period.
RGCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Regencell Investors Sue Over Undisclosed DOJ Probe, Stock Plunges 18.56%

Class action lawsuit filed against Regencell Bioscience for alleged false statements and failure to disclose DOJ investigation into trading practices.
RGCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Regencell Faces Securities Class Action Over Alleged False Statements, Disclosure Failures

Rosen Law Firm filed class action lawsuit against Regencell Bioscience ($RGC) alleging false statements and regulatory risk non-disclosure. Lead plaintiff deadline: June 23, 2026.
RGCSESSES.WSGLOBsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Regencell Faces Class Action Lawsuit Over Market Manipulation Disclosures

Class action filed against $REGENCELL for alleged false statements regarding market manipulation vulnerability and regulatory exposure between October 2024-2025.
RGCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Globant Faces Securities Class Action Over Latin America Strategy Misrepresentation

Rosen Law Firm sues Globant ($GLOB) alleging misrepresentation of Latin American strategy success amid declining demand, client losses, and wage freezes.
RGCSESSES.WSGLOBsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Gainey Mckenna & Egleston

Securities Suit Filed Against $RGC Over Alleged Market Manipulation Disclosure Gaps

Class action lawsuit filed against $RGC for failing to disclose market manipulation vulnerabilities. June 23, 2026 deadline for lead plaintiff claims.
RGCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Class Action Filed Against $RGC Over Alleged Market Manipulation Vulnerability

Law firm files class action against Regencell Bioscience ($RGC) alleging false statements about market manipulation risks. Investors urged to join case by June 23, 2026 deadline.
RGCsecurities fraudclass action lawsuit
BenzingaBenzinga··Nabaparna Bhattacharya

VinFast Surges 43% as EV and Commodity Stocks Lead Market Rally

Large-cap stocks posted strong gains during shortened week. VinFast led with 42.77% surge, while Alcoa and infrastructure stocks gained 20%+.
AAEQXAUCDELITE+6stock marketprecious metals
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Regencell's 21,000% Surge Masks Fundamental Risks in Unproven Biotech

Regencell Bioscience surged 21,000% despite zero revenue and no approved products, exemplifying speculative excess that investors should avoid.
PFERGCpenny stockdrug development
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Shareholder Law Firm Probes Regencell, Camping World Over Securities Violations

Shareholder law firm investigates Regencell and Camping World for securities violations. Regencell faces DOJ trading probe; Camping World disclosed accounting restatements, Q4 losses, and suspended dividends.
CWHRGCshareholder rightssecurities investigation
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Pfizer's Boring Appeal: Why Blue-Chip Stability Beats Biotech Hype

Pfizer's reasonable valuation, robust pipeline, and 6.4% dividend yield offer disciplined returns versus speculative biotech like Regencell, whose 21,000% surge lacks fundamental justification.
PFERGCstock valuationclinical trials